Seaport Therapeutics News and Activities

Seaport Therapeutics is owned by PureTech.

PureTech is one of the...

• FTSE SmallCaps.

PureTech is a company listed under the stock ticker PRTC (US).

Acquisition, funding and merger involving PureTech.

• Seaport Therapeutics has filed its IPO. Its stock ticker will be SPTX. (posted on April 15 2026).
• Seaport Therapeutics has just announced a $225 Million fundraising (posted on October 25 2024).

View the org chart displaying its 27 main executives

Most searched biographies at Seaport Therapeutics

• Daphne Zohar, Chief Executive Officer
• Sandi Peterson, Director
• Jason Pitts, Director

Popular executive movements at Seaport Therapeutics

• Sharon Mates has joined the company as Director  (posted on April 28 2026).
• Emily Pierce who was Senior Manager, Bioanalytical Sciences, becomes Associate Director, Bioanalysis  (posted on April 16 2026).
• Eric Green, Chief Operating Officer, has left the company  (posted on April 16 2026).

Popular executive movements at PureTech

• Robert Lyne, who was Interim Chief Executive Officer, is promoted to Chief Executive Officer  (posted on December 18 2025).

Create your alert
to follow the executive moves at Seaport Therapeutics.

PureTech has 2,430 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Tempus has announced the acquisition of Personalis  (posted on July 20 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Seaport Therapeutics

• Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering – Seaport Therapeutics
• News Releases – Seaport Therapeutics
• Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors – Seaport Therapeutics
• Seaport Therapeutics Adds Sandi Peterson to its Board of Directors – Seaport Therapeutics
• Seaport Therapeutics Names Lauren White as Chief Financial Officer – Seaport Therapeutics
• Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round – Seaport Therapeutics
• Seaport Therapeutics Appoints Seasoned Executives to Management Team – Seaport Therapeutics
• Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors – Seaport Therapeutics
• Papers – Seaport Therapeutics
• News – Seaport Therapeutics
• View more press releases Close

Social media about Seaport Therapeutics

• Seaport Therapeutics on Wikipedia, Google News & Yahoo Finance
• Seaport Therapeutics on LinkedIn, X (Twitter) & YouTube